Dovato® (dolutegravir and lamivudine)
for Human Immunodeficiency Virus

Dovato (dolutegravir and lamivudine) is a two-drug HIV-1 treatment for adults and adolescents aged 12 and older, weighing at least 25 kg. It contains dolutegravir and lamivudine, which work at different stages of the HIV replication process to reduce the virus in the blood. Dovato offers a simplified approach to managing HIV by helping to lower viral levels and support immune health.

Heart
Other top medicines used to treat Human Immunodeficiency Virus - HIV